Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 4 , Pages 417-422 , December 2007

Prenatal Diagnosis and Perinatal Management of Maternal—Fetal Congenital Parvovirus B19 Infection

,Accepted 25 April 2007.

References 

  1. Guerrero LD . Fetal parvovirus infection . Available at: http://www.thefetus.net/page.php?id=155 [Date accessed: 21 December 2006]
  2. Cunningham D , Rennels MB . Parvovirus B19 infection . Available at: http://www.emedicine.com/ped/topic192.htm [Date accessed: 21 December 2006]
  3. Tolfvenstam T , Papadogiannakis N , Norbeck O , Petersson K , Broliden K . Frequency of human parvovirus B19 infection in intrauterine fetal death . Lancet . 2001;357:1494–1497
  4. Gillespie SM , Cartter ML , Asch S , et al.   Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum . JAMA . 1990;263:2061–2065
  5. von Kaisenberg CS , Bender G , Scheewe J , et al.   A case of fetal parvovirus B19 myocarditis, terminal cardiac heart failure, and perinatal heart transplantation . Fetal Diagn Ther . 2001;16:427–523
  6. Nagel HT , de Haan TR , Vandenbussche FP , Oepkes D , Walther FJ . Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection . Obstet Gynecol . 2007;109:42–47
  7. Delle Chiaie L , Buck G , Grab D , Terinde R . Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or par-vovirus B19 infection . Ultrasound Obstet Gynecol . 2001;18:232–236
  8. Lynch L , Mehalek K , Berkowitz RL . Invasive fetal therapy . In:  Rodeck CH editors. Fetal Medicine . 1st edition. Oxford: Blackwell Scientific Publications; 1989;p. 118–153
  9. Bowman JM , Manning FA . Intrauterine fetal transfusions: Winnipeg 1982 . Obstet Gynecol . 1983;61:203–209
  10. Bowman JM . Maternal blood group immunization . In:  Eden RD ,  Boehm FH editor. Assessment and Care of the Fetus . international edition. East Norwalk: Appleton & Lange; 1990;p. 749–766
  11. Watts DH , Luthy DA , Benedetti TJ , Cyr DR , Easterling TR , Hickok D . Intraperitoneal fetal transfusion under direct ultrasound guidance . Obstet Gynecol . 1988;71:84–88
  12. Rodeck CH , Nicolaides KH , Warsof SL , Fysh WJ , Gamsu HR , Kemp JR . The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions . Am J Obstet Gynecol . 1984;150:769–774
  13. Smoleniec JS , Pillai M . Management of fetal hydrops associated with parvovirus B19 infection . Br J Obstet Gynaecol . 1994;101:1079–1081
  14. Forestier F , Tissot JD , Vial Y , Daffos F , Hohlfeld P . Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis . Br J Haematol . 1999;104:925–927
  15. Naides SJ , Weiner CP . Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection . Prenat Diagn . 1989;9:105–114
  16. Frishman WH , O'Brien M , Naseer N , Anandasabapathy S . Innovative drug treatments for viral and autoimmune myocarditis . Heart Dis . 2002;4:171–183

PII: S1028-4559(08)60014-5

doi: 10.1016/S1028-4559(08)60014-5

Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 4 , Pages 417-422 , December 2007

Article Tools